Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

NorgesInvestor

Founders Jan Gunnar Hartvig Trond E Wennberg

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$27M
Portfolio companies 1
Rounds per year 0.04
Lead investments 0
Exits 1
Key employees 2
Stages of investment
Private Equity

Areas of investment

  • Medical
  • Biotechnology
  • Chemical
Summary

The venture was found in Europe in Norway. The main office of represented VC is situated in the Oslo.

For fund there is a match between the location of its establishment and the land of its numerous investments - Norway. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Algeta. We can highlight the next thriving fund investment areas, such as Chemical, Biotechnology.

The important activity for fund was in 2005. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2007. The fund is generally included in less than 2 deals every year.

The typical case for the fund is to invest in rounds with 5 participants. The meaningful sponsors for the fund in investment in the same round are SR One, HealthCap, Advent Venture Partners. In the next rounds fund is usually obtained by Abingworth.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AEP Capital New York, New York, United States
Ambient Sound Investments Estonia, Harjumaa, Tallinn
Cedar Mundi Ventures Beirut, Beyrouth, Lebanon
Circularity Capital City of Edinburgh, Scotland, United Kingdom
Ignite Growth Brands New Jersey, Princeton, United States
Ingram Content Group La Vergne, Tennessee, United States
J Ventures New York, New York, United States
Jintanglang China, Guangxi, Jiangsu
Kaihuo Shangwu China, Hunan, Longhui
Norwest Mezzanine Partners Minneapolis, Minnesota, United States
OGCI Climate Investments England, London, United Kingdom
Ojas Venture Partners Bangalore, India, Karnataka
Old Willow Partners Minnesota, Northfield, United States
Proteus Digital Health California, Redwood City, United States
Rogue Capital California, San Francisco, United States
Shanghai Nuokai Investment Management China, Shanghai
Still Capital Partners -
Tsinghua Venture Capital Beijing, Beijing, China
Zhongzhi Hulian China, Futian, Guangdong

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Algeta

Biotechnology
Chemical
Medical
$27M02 Sep 2005 Oslo, Norway

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent NorgesInvestor?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 27M
Rounds per year 0.04
Peak activity year 2005
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Algeta

Biotechnology
Chemical
Medical
$27M02 Sep 2005 Oslo, Norway
Crunchbase icon

Content report

The following text will be sent to our editors: